BIOT — Biotage AB Cashflow Statement
0.000.00%
Last trade - 00:00
- SEK13.89bn
- SEK13.55bn
- SEK1.86bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 212 | 223 | 269 | 348 | 303 |
Depreciation | |||||
Non-Cash Items | 2.13 | -11.7 | 4 | -17 | 14 |
Other Non-Cash Items | |||||
Changes in Working Capital | -76.7 | -5.92 | 5 | -92 | -182 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 212 | 279 | 353 | 341 | 284 |
Capital Expenditures | -45.5 | -60.9 | -56 | -70 | -91 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -40.2 | -0.379 | -285 | -14 | 126 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -85.7 | -61.3 | -341 | -84 | 35 |
Financing Cash Flow Items | — | — | — | -1 | — |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -119 | -22.7 | -82 | -133 | -142 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 8.85 | 185 | -61 | 131 | 153 |